Evidence map

TrialPloS one2015

Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.

Sanne M van der Made et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

67 papers cite itlatest 60 shown

2015
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 25790328